Sotera Health Co. (SHC) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$16.07

From 52W high−15.07%

Volume1.78M

Market cap$4.75B

P/E (TTM)27.5x

P/S (TTM)3.9x

Div yield—

Key dataNov 4, 2026

Open

$16.07

From 52W high

−15.07%

Volume

1.78M

Market cap

$4.75B

ValuationView details →

P/E (Fwd)

15.8x

EV/EBITDA

12.2x

P/E (TTM)

27.5x

RSI (14)

34.0

MomentumView details →

1D Return

+3.68%

YTD Return

−6.49%

SummaryUpdated Sep 1, 2026

Sotera Health Company (NASDAQ:SHC) is a mission-critical sterilization and laboratory testing services provider that went public in November 2020. Founded in 2017 and headquartered in Broadview Heights, Ohio, the company operates through three main business segments serving the medical device, pharmaceutical, and food industries. Sotera Health has achieved 19 consecutive years of revenue growth and plays an essential role in ensuring the safety and efficacy of medical products before they reach patients and consumers.

Ask drillr about Sotera Health Co. →

ValuationView details →

P/E (Fwd)

15.8x

P/E (TTM)

27.5x

EV/EBITDA

12.2x

EV/Sales

5.4x

P/S (TTM)

3.9x

P/B (TTM)

6.5x

ProfitabilityView details →

Gross Margin

54.38%

Net Margin

14.11%

EBITDA Margin

44.11%

ROE (TTM)

23.66%

ROA (TTM)

5.12%

Asset Turnover

0.37x

GrowthView details →

Revenue YoY

+6.90%

EPS YoY

+210.18%

FCF YoY

+56.36%

Revenue CAGR 3Y

+5.05%

EPS CAGR 3Y

+22.47%

EBITDA YoY

+26.70%

MomentumView details →

1D Return

+3.68%

YTD Return

−6.49%

1Y Return

+4.33%

RSI (14)

34.0

vs 50D SMA

−10.16%

vs 200D SMA

−2.79%

Capital & dividendView details →

Debt/Equity

3.10x

Current Ratio

3.13x

Quick Ratio

2.91x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.29

EPS Surprise

7.93%

Beats (12Q)

8/12

Next Q EPS Est

$0.28

Avg Surprise (4Q)

7.74%

Rev Surprise

1.57%

Financials snapshotView financials →

Revenue (TTM)

1.23B

Net Income (TTM)

173.47M

Op. CF (TTM)

331.58M

Next earningsFeb 23, 2027 →

Latest newsMore news →

Sotera Health Co reaffirmed its full-year 2026 outlook for constant-currency net revenue growth of 5.25%–6.75% and Adjusted EBITDA growth of 5.75%–7.25%.1d ago

Sotera Health Co reported third-quarter 2026 net revenues up 4.4% year over year, net income of $58 million, Adjusted EBITDA up 3.9%, and Adjusted EPS of $0.29, up 12%.1d ago

Similar companies

CareDx, IncCDNA BillionToOne, Inc.BLLN 润达医疗603108.SH 塞力医疗603716.SH RadNet, Inc.RDNT GRAIL, Inc.GRAL Find similar companies →

Latest newsMore news →

Sotera Health Co reaffirmed its full-year 2026 outlook for constant-currency net revenue growth of 5.25%–6.75% and Adjusted EBITDA growth of 5.75%–7.25%.1d ago Sotera Health Co reported third-quarter 2026 net revenues up 4.4% year over year, net income of $58 million, Adjusted EBITDA up 3.9%, and Adjusted EPS of $0.29, up 12%.1d ago Sotera Health announced that it plans to release its third-quarter 2026 financial results before the market opens on November 3, 2026.14d ago